Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?Zacks Investment Research • Tuesday
Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or State Street's XLV?The Motley Fool • Monday
Big pharma stocks near all-time highs as tech selloff pushes investors toward safer betsMarket Watch • 10/15/26
Bet on These Healthcare ETFs to Benefit From the Aging US PopulationZacks Investment Research • 10/14/26
XLV vs IBB: How Healthcare Diversification Compares to Biotech ConcentrationThe Motley Fool • 09/24/26
XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma StocksThe Motley Fool • 09/23/26
Heard on the Street: With the Food and Drug Administration's hard-liners gone, investors are rushing back into rare-disease betsWSJ • 09/16/26
State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for InvestorsThe Motley Fool • 09/13/26
Midterm Takes Center Stage: What Does It Mean for Markets & ETFs?Zacks Investment Research • 09/11/26
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%24/7 Wall Street • 09/08/26